ROYALTY PHARMA INVESTMENTS 2019 ICAV enters EPIZYME, INC. with 22.67M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 2/9/2022ACC: 0000899243-22-005424
Director10% Owner
Since Jan 2022
22.67M
Baseline shares
100% direct
22.67M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned22.67M
Total
22.67M direct22.67M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 22.67M | Direct |
| Total | 22.67M | 22.67M direct |
Derivative Holdings0
No derivative holdings reported